FLT3 and acute lymphoblastic leukemia: However, FLAG-containing regimens with consolidating allogeneic transplantation and sorafenib maintenance treatment in case of activating FLT3 mutations not only are regular salvage approaches in refractory AML but also have been described as a successful therapy in ETP-ALL (51).